Neural Mechanisms Underlying Alcohol Induced Disinhibition

NCT ID: NCT01097213

Last Updated: 2013-03-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-12-31

Study Completion Date

2012-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Forty 18-year-old social drinkers will be selected from the sample tested in specific aim 1 ("Prospective Assessment of Adolescent Drinking Trajectories With Computer-Assisted Self-administration of Ethanol (CASE)"; ClinicalTrials.gov identifier: NCT01063166). The functional magnetic resonance imaging blood-oxygen-level-dependent (fMRI BOLD) activity related to disinhibition measured with the Stop Signal task will be assessed during a continuous infusion of alcohol, clamping the arterial Breath Alcohol Concentration (aBAC) at 60 mg% for approximately one hour. It will be examined whether this fMRI BOLD activity is associated with the initial drinking trajectories and the alcohol consumption at age 18 and at age 20 identified in specific aim 1. Furthermore, fMRI will be used with the Taylor Aggression Paradigm to determine which brain areas mediate increased physical aggression during the same continuous infusion of alcohol as described above. All participants will undergo an alcohol and a placebo fMRI session.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alcoholism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ethanol

Intravenous infusion of 6% ethanol in half-normal saline for approximately 1 hour: The dosage is controlled by a physiologically-based pharmacokinetic (PBPK) model of alcohol distribution and elimination, developed by O'Connor and his associates at the Indiana Alcohol Research Center (IARC) (Ramchandani et al, 1999). PBPK Parameters that determine the dosage and frequency of the infusion for a specific individual are estimated by means of morphometric variables (age, height, weight and gender).

Intervention Type DRUG

Placebo - half-normal saline

Intravenous infusion of half-normal saline for approximately 1 hour: The dosage is equal to the infusion dosage estimated by the PBPK model of alcohol distribution and elimination (Ramchandani et al., 1999) for the drug - ethanol condition.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* male and female Caucasian volunteers aged 18 years/0 months to 19 years/11 months;
* written informed consent by the subject;
* habitual social drinking during the two months preceding participation, defined by at least one drinking day in any two weeks-interval;
* at least one prior experience of alcohol intoxication
* being able to abstain from tobacco use for four hours without developing nicotine withdrawal symptoms;
* effective contraception in female participants;
* consenting to abstain from any illegal substance use for 2 weeks prior to participation;
* living within 15 km (9.5 miles) from downtown Dresden;
* sufficient information concerning alcohol use in both parents and in at least four second-degree relatives

Exclusion Criteria

* prior medical treatment due to alcohol use;
* current or prior history of any serious disease, including CNS, cardiovascular, respiratory, gastrointestinal, hepatic, renal, endocrine, alcohol or drug dependence, but not alcohol abuse;
* current history of Axis-I psychiatric illness, including premenstrual dysphoric disorder;
* current or prior history of alcohol-induced flushing reactions;
* positive urine screen for cannabinoids, cocaine, amphetamines, opiates, or benzodiazepines;
* light or non-drinkers: averaging less than 2 standard drinks per week in the preceding two months;
* intention to become pregnant
* pregnancy or positive urine pregnancy screening or breast-feeding;
* any alcohol intake on the test day or the day before;
* use of medications known to interact with alcohol within 2 weeks of the study;
* positive hepatitis or HIV at screening, provided the subject consented to these tests
* any conditions posing safety issues with the fMRI scan, such as ferromagnetic implants, cardiac pacemakers or insulin pumps
Minimum Eligible Age

18 Years

Maximum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Indiana University School of Medicine

OTHER

Sponsor Role collaborator

Technische Universität Dresden

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael N. Smolka, Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

Technische Universitaet Dresden - - Faculty of Medicine Carl Gustav Carus - Department of Psychiatry and Psychotherapy

Ulrich S. Zimmermann, Dr.

Role: PRINCIPAL_INVESTIGATOR

Universitaetsklinikum Carl Gustav Carus at the Technische Universitaet Dresden

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Technische Universitaet Dresden - Dresden fMRT-Neuroimaging Center

Dresden, Saxony, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

References

Explore related publications, articles, or registry entries linked to this study.

Gan G, Guevara A, Marxen M, Neumann M, Junger E, Kobiella A, Mennigen E, Pilhatsch M, Schwarz D, Zimmermann US, Smolka MN. Alcohol-induced impairment of inhibitory control is linked to attenuated brain responses in right fronto-temporal cortex. Biol Psychiatry. 2014 Nov 1;76(9):698-707. doi: 10.1016/j.biopsych.2013.12.017. Epub 2014 Jan 15.

Reference Type DERIVED
PMID: 24560581 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

U01AA017900

Identifier Type: NIH

Identifier Source: secondary_id

View Link

U01 AA017900 SA2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

EtOH Interaction Study
NCT00887367 COMPLETED PHASE1